Obstructive sleep apnoea syndrome and its management
- PMID: 26336596
- PMCID: PMC4549693
- DOI: 10.1177/2040622315590318
Obstructive sleep apnoea syndrome and its management
Abstract
Obstructive sleep apnoea (OSA) is a common disorder characterized by repetitive episodes of nocturnal breathing cessation due to upper airway collapse. OSA causes severe symptoms, such as excessive daytime somnolence, and is associated with a significant cardiovascular morbidity and mortality. Different treatment options are now available for an effective management of this disease. After more than three decades from its first use, continuous positive airway pressure (CPAP) is still recognized as the gold standard treatment. Nasal CPAP (nCPAP) is highly effective in controlling symptoms, improving quality of life and reducing the clinical sequelae of sleep apnoea. Other positive airway pressure modalities are available for patients intolerant to CPAP or requiring high levels of positive pressure. Mandibular advancement devices, particularly if custom made, are effective in mild to moderate OSA and provide a viable alternative for patients intolerant to CPAP therapy. The role of surgery remains controversial. Uvulopalatopharyngoplasty is a well established procedure and can be considered when treatment with CPAP has failed, whereas maxillar-mandibular surgery can be suggested to patients with a craniofacial malformation. A number of minimally invasive procedures to treat snoring are currently under evaluation. Weight loss improves symptoms and morbidity in all patients with obesity and bariatric surgery is an option in severe obesity. A multidisciplinary approach is necessary for an accurate management of the disease.
Keywords: continuous positive airway pressure; obstructive sleep apnoea; oral appliance; positional therapy; uvulopalatopharyngoplasty.
Conflict of interest statement
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4549693/bin/10.1177_2040622315590318-fig1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4549693/bin/10.1177_2040622315590318-fig2.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4549693/bin/10.1177_2040622315590318-fig3.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4549693/bin/10.1177_2040622315590318-fig4.gif)
Similar articles
-
Obstructive Sleep Apnoea Syndrome: A Systematic Literature Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2007 Jun. SBU Assessment No. 184. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2007 Jun. SBU Assessment No. 184. PMID: 28876733 Free Books & Documents. Review.
-
Beyond Usual Care: A Multidisciplinary Approach Towards the Treatment of Obstructive Sleep Apnoea.Front Cardiovasc Med. 2022 Jan 5;8:747495. doi: 10.3389/fcvm.2021.747495. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35071340 Free PMC article. Review.
-
Oral appliance therapy for obstructive sleep apnea.Treat Respir Med. 2005;4(6):409-22. doi: 10.2165/00151829-200504060-00005. Treat Respir Med. 2005. PMID: 16336026 Review.
-
Drug therapy for obstructive sleep apnoea in adults.Cochrane Database Syst Rev. 2013 May 31;(5):CD003002. doi: 10.1002/14651858.CD003002.pub3. Cochrane Database Syst Rev. 2013. PMID: 23728641 Review.
-
Continuous positive airways pressure for obstructive sleep apnoea in adults.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001106. doi: 10.1002/14651858.CD001106.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001106. doi: 10.1002/14651858.CD001106.pub3. PMID: 16437429 Updated. Review.
Cited by
-
Quality of Life, Mental Health, and CPAP Compliance in Thai Patients with Obstructive Sleep Apnea during COVID-19 Pandemic.Sleep Disord. 2024 Apr 23;2024:1373299. doi: 10.1155/2024/1373299. eCollection 2024. Sleep Disord. 2024. PMID: 38695014 Free PMC article.
-
Computational Rhinology: Unraveling Discrepancies between In Silico and In Vivo Nasal Airflow Assessments for Enhanced Clinical Decision Support.Bioengineering (Basel). 2024 Feb 28;11(3):239. doi: 10.3390/bioengineering11030239. Bioengineering (Basel). 2024. PMID: 38534513 Free PMC article. Review.
-
A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness.Psychopharmacol Bull. 2024 Mar 4;54(1):65-86. Psychopharmacol Bull. 2024. PMID: 38449471 Review.
-
The impact of obstructive sleep apnea treatment on microvascular complications in patients with type 2 diabetes: a feasibility randomized controlled trial.J Clin Sleep Med. 2024 Jun 1;20(6):947-957. doi: 10.5664/jcsm.11020. J Clin Sleep Med. 2024. PMID: 38318821 Clinical Trial.
-
Anterolateral advancement pharyngoplasty versus barbed reposition pharyngoplasty in patients with obstructive sleep apnea.Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1991-2000. doi: 10.1007/s00405-023-08402-1. Epub 2024 Jan 3. Eur Arch Otorhinolaryngol. 2024. PMID: 38170209 Free PMC article. Clinical Trial.
References
-
- Aloia M., Ilniczky N., Di Dio P., Perlis M., Greenblatt D., Giles D. (2003) Neuropsychological change and treatment compliance in older adults with sleep apnea. J Psychosom Res 54: 71–76. - PubMed
-
- Antonopoulos C., Sergentanis T., Daskalopoulou S., Petridou E. (2011) Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis. Sleep Med Rev 15: 301–310. - PubMed
-
- Ashrafian H., Toma T., Rowland S., Harling L., Tan A., Efthimiou E., et al. (2015) Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg 25: 1239–50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25537297 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources